Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 326 followers
Latest posts
Last updated 28 minutes ago
Flagship-founded antibody biotech Generate is latest to mull IPO
28 minutes ago
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public...
Quell halts liver transplant Treg trial to focus on preclinical ‘chill not kill’ candidate
about 4 hours ago
Quell Therapeutics is pressing pause on an engineered regulatory T cell therapy...
Eikon’s upsized $381M Nasdaq listing marks largest biotech IPO since 2024
about 5 hours ago
Eikon Therapeutics is heading to the Nasdaq this morning with an upsized...
FDA’s rare pediatric disease voucher program revived by 2026 government funding bill
about 19 hours ago
By signing a government funding bill that ended a partial shutdown, President...
Lilly drops 3 pipeline drugs, including gene therapy from $1B Prevail buyout
about 21 hours ago
As Eli Lilly awaits an FDA approval decision for its oral GLP-1...
Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates
about 22 hours ago
Novartis has nixed six early-stage pipeline programs, swapping in two new phase...
Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform
about 23 hours ago
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri...
Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq
about 24 hours ago
Stem cell therapy biotech PrimeGen US is taking the less-traveled SPAC route...
FDA demands better response from Abbott over Libre inspection violations
1 day ago
Abbott has been hit with a slew of complaints from the FDA...
Medtronic 'steps up' with up to $585M deal for Israeli devicemaker CathWorks
1 day ago
Just weeks after announcing it would "step up" its acquisitions this year...
GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'
1 day ago
Luke Miels had only been at the helm of GSK for 20...
Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
1 day ago
Novo Nordisk’s CEO was magnanimous about Pfizer’s victory in last year’s bidding...